22.35
price down icon3.08%   -0.71
after-market Handel nachbörslich: 22.41 0.06 +0.27%
loading
Schlusskurs vom Vortag:
$23.06
Offen:
$23.06
24-Stunden-Volumen:
432.29K
Relative Volume:
0.68
Marktkapitalisierung:
$1.00B
Einnahmen:
$681.75M
Nettoeinkommen (Verlust:
$70.47M
KGV:
15.41
EPS:
1.45
Netto-Cashflow:
$173.19M
1W Leistung:
-10.02%
1M Leistung:
-16.01%
6M Leistung:
-5.66%
1J Leistung:
+44.10%
1-Tages-Spanne:
Value
$22.30
$23.06
1-Wochen-Bereich:
Value
$22.30
$25.30
52-Wochen-Spanne:
Value
$15.50
$27.98

Pacira Biosciences Inc Stock (PCRX) Company Profile

Name
Firmenname
Pacira Biosciences Inc
Name
Telefon
650-242-8052
Name
Adresse
2000 SIERRA POINT PARKWAY, BRISBANE, NJ
Name
Mitarbeiter
790
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
PCRX's Discussions on Twitter

Vergleichen Sie PCRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
PCRX
Pacira Biosciences Inc
22.35 1.04B 681.75M 70.47M 173.19M 1.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
141.11 63.55B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.71 44.47B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.00 40.17B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.03 22.99B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
440.00 20.14B 3.08B 1.24B 1.07B 25.61

Pacira Biosciences Inc Stock (PCRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-25 Hochstufung Truist Hold → Buy
2025-01-30 Hochstufung Truist Sell → Hold
2024-08-13 Herabstufung Truist Buy → Sell
2024-08-12 Herabstufung JP Morgan Overweight → Underweight
2024-08-12 Herabstufung Piper Sandler Overweight → Neutral
2024-08-12 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2024-08-12 Herabstufung Raymond James Outperform → Mkt Perform
2024-07-03 Herabstufung Barclays Overweight → Equal Weight
2024-03-07 Fortgesetzt JP Morgan Overweight
2023-12-20 Eingeleitet Raymond James Outperform
2023-08-03 Hochstufung TD Cowen Market Perform → Outperform
2023-01-31 Fortgesetzt Wedbush Outperform
2022-10-21 Fortgesetzt Jefferies Buy
2022-01-03 Fortgesetzt JP Morgan Overweight
2021-07-26 Hochstufung JP Morgan Neutral → Overweight
2021-04-21 Fortgesetzt JP Morgan Neutral
2021-04-09 Eingeleitet Berenberg Buy
2021-04-07 Fortgesetzt RBC Capital Mkts Outperform
2021-02-11 Herabstufung Northland Capital Outperform → Market Perform
2021-01-21 Herabstufung SVB Leerink Outperform → Mkt Perform
2020-09-21 Hochstufung Northland Capital Market Perform → Outperform
2020-07-06 Bestätigt Needham Buy
2020-05-27 Eingeleitet Guggenheim Neutral
2020-04-07 Eingeleitet Northland Capital Outperform
2020-03-20 Hochstufung SVB Leerink Mkt Perform → Outperform
2020-02-24 Bestätigt H.C. Wainwright Buy
2020-01-24 Eingeleitet SunTrust Buy
2020-01-23 Eingeleitet SunTrust Buy
2019-11-06 Eingeleitet BTIG Research Buy
2019-06-11 Eingeleitet Barclays Overweight
2019-05-06 Hochstufung Mizuho Underperform → Neutral
2019-05-02 Hochstufung Stifel Sell → Hold
2019-02-01 Herabstufung Mizuho Neutral → Underperform
2018-08-06 Herabstufung BofA/Merrill Buy → Neutral
2018-04-09 Bestätigt H.C. Wainwright Buy
2018-03-21 Bestätigt Mizuho Neutral
2018-02-16 Herabstufung Needham Buy → Hold
2018-01-19 Eingeleitet Seaport Global Securities Buy
2018-01-04 Bestätigt Canaccord Genuity Buy
2018-01-03 Eingeleitet Leerink Partners Mkt Perform
Alle ansehen

Pacira Biosciences Inc Aktie (PCRX) Neueste Nachrichten

pulisher
09:47 AM

How Pacira BioSciences Inc. (82P) stock behaves under inflation pressureWeekly Earnings Recap & Low Risk High Reward Ideas - newser.com

09:47 AM
pulisher
08:06 AM

Pacira BioSciences (NASDAQ:PCRX) Given "Sell (D)" Rating at Weiss Ratings - MarketBeat

08:06 AM
pulisher
07:20 AM

How to interpret RSI for Pacira BioSciences Inc. stock2025 Big Picture & Advanced Swing Trade Entry Plans - newser.com

07:20 AM
pulisher
06:21 AM

Detecting support and resistance levels for Pacira BioSciences Inc.July 2025 Sector Moves & Fast Entry and Exit Trade Plans - newser.com

06:21 AM
pulisher
05:55 AM

Will Pacira BioSciences Inc. (82P) stock split increase liquidityEarnings Performance Report & Stepwise Entry and Exit Trade Signals - newser.com

05:55 AM
pulisher
05:50 AM

Pacira BioSciences Inc. stock trend outlook and recovery path2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - newser.com

05:50 AM
pulisher
03:14 AM

What moving averages say about Pacira BioSciences Inc.Weekly Trend Report & Weekly Top Gainers Alerts - newser.com

03:14 AM
pulisher
Oct 09, 2025

Pacira BioSciences Inc. stock volume spike explained2025 Price Targets & Fast Entry High Yield Stock Tips - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

What momentum shifts mean for Pacira BioSciences Inc.Inflation Watch & Consistent Return Investment Signals - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Custom watchlist performance reports with Pacira BioSciences Inc.2025 Stock Rankings & Growth Oriented Trading Recommendations - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Pacira BioSciences Becomes Oversold (PCRX) - Nasdaq

Oct 08, 2025
pulisher
Oct 08, 2025

Pacira BioSciences, Inc. $PCRX Shares Bought by Gagnon Securities LLC - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

Gagnon Advisors LLC Has $5.10 Million Position in Pacira BioSciences, Inc. $PCRX - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

Robeco Institutional Asset Management B.V. Has $1.29 Million Holdings in Pacira BioSciences, Inc. $PCRX - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

Pacira Biosciences, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 07, 2025
pulisher
Oct 07, 2025

Possible Bearish Signals With Pacira BioSciences Insiders Disposing Stock - simplywall.st

Oct 07, 2025
pulisher
Oct 06, 2025

Raymond James Maintains Pacira BioSciences(PCRX.US) With Hold Rating - 富途牛牛

Oct 06, 2025
pulisher
Oct 06, 2025

Applying Elliott Wave Theory to Pacira BioSciences Inc.Fed Meeting & Smart Money Movement Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Long term hold vs stop loss in Pacira BioSciences Inc.July 2025 Macro Moves & Stepwise Trade Signal Implementation - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Stockholders to Connect - ACCESS Newswire

Oct 05, 2025
pulisher
Oct 05, 2025

Will Pacira BioSciences Inc. stock gain from government policiesWeekly Risk Report & Capital Efficiency Focused Strategies - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Using Bollinger Bands to evaluate Pacira BioSciences Inc.Chart Signals & Entry Point Confirmation Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Can Pacira BioSciences Inc. (82P) stock hold up in economic slowdownPrice Action & Daily Stock Momentum Reports - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Greenwood Capital Associates LLC Takes $314,000 Position in Pacira BioSciences, Inc. $PCRX - MarketBeat

Oct 04, 2025
pulisher
Oct 03, 2025

Why Institutions Believe Medinova Diagnostic Services Limited Is Undervalued TodayDividend Aristocrats List & Free Unlock Portfolio Growth - earlytimes.in

Oct 03, 2025
pulisher
Oct 03, 2025

What drives Pacira BioSciences Inc stock priceLarge Cap Stability Picks & Today’s Picks, Tomorrow’s Winners - earlytimes.in

Oct 03, 2025
pulisher
Oct 03, 2025

Pacira Biosciences (PCRX) Grants Inducement Awards to New Employ - GuruFocus

Oct 03, 2025
pulisher
Oct 03, 2025

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Oct 03, 2025
pulisher
Oct 03, 2025

Pacira BioSciences reports inducement grants - MarketScreener

Oct 03, 2025
pulisher
Oct 03, 2025

50,600 Shares: Pacira Grants Inducement Awards to 15 New Employees; $24.58 Exercise Price - Stock Titan

Oct 03, 2025
pulisher
Oct 03, 2025

Why Pacira BioSciences Inc. (82P) stock could outperform next yearPortfolio Performance Summary & Growth Focused Investment Plans - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Farther Finance Advisors LLC Boosts Holdings in Pacira BioSciences, Inc. $PCRX - Defense World

Oct 02, 2025
pulisher
Sep 30, 2025

Pacira BioSciences, Inc. (PCRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Sep 30, 2025
pulisher
Sep 30, 2025

Is Ganga Forging Limited Still a Good Stock to Buy After Recent EarningsSupport Zone Identification & Big Profit Small Budget - earlytimes.in

Sep 30, 2025

Finanzdaten der Pacira Biosciences Inc-Aktie (PCRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$19.76
price down icon 1.54%
$9.74
price down icon 2.50%
$53.95
price down icon 7.38%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.20%
$136.63
price down icon 1.33%
$440.00
price down icon 1.21%
Kapitalisierung:     |  Volumen (24h):